In summary, our results highlight the central role of SRR2 to maintain high levels of SOX2 expression, and hence malignant properties of glioma cells establishing the requirement for this regulatory region for SOX2-driven tumorigenic activities. Here, SOX2 is linked to central nervous system cancer.